Key facts
- This page summarizes Emil E. Hassan's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
- 2 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 01 May 2026, 16:45.
Emil E. Hassan - 30 Apr 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)
- Reporting relationship
- Director
- Issuer ticker
- NHC
- Reported as of
- 30 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 May 2026, 16:45:33 UTC
- Prior SEC filing
- 26 Nov 2025
- Next SEC filing
- 07 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Emil E. Hassan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Emil E. Hassan filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 01 May 2026.
Change
- Previous filing in this sequence was filed on 26 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001288063
Primary reporting owner
HASSAN EMIL E
- Relationship
- Director
- Address
- 100 VINE STREET, MURFREESBORO
- Signature
- /s/ Emil E. Hassan
- Signature date
- 01 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NHC
transaction
Shares of Common Stock
Options Exercise
- Transaction value
- Shares
- +7,500
- Change %
- +11%
- Price
- $71.64*
- Shares after
- 73,095
- Date
- 30 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NHC
transaction
Derivative
Option to Purchase Common Stock [2021 Grant]
Options Exercise
- Transaction value
- Shares
- -7,500
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $71.64
- Footnotes
- F1
NHC
holding
Derivative
Option to Purchase Common Stock [2022 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $69.19
NHC
holding
Derivative
Option to Purchase Common Stock [2023 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $55.75
NHC
holding
Derivative
Option to Purchase Common Stock [2024 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $96.03
NHC
holding
Derivative
Option to Purchase Common Stock [2025 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $94.66
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).